OZN

C. Difficile Toxin Gene Amplification Assay

Product code
OZN
Device name
C. Difficile Toxin Gene Amplification Assay
Device class
Class 2
21 CFR
21 CFR 866.3130
Medical specialty
Microbiology
Marketing pathway
510(K)
510(k) clearances (last 3 years)
3
Summaries archived here
3 (direct download)
510(k) clearances (all years, FDA)
18 (all years; only the last 3 years are listed here)

FDA classification definition

Amplification assay for the detection of c. Difficile toxin genes from stool specimens of symptomatic patients.

Definition text from the FDA device classification database (U.S. federal government work, public domain).

510(k) clearances, last 3 years (3)

Last three years. Most recent: 2026-08-28.

NumberDecision dateApplicantDevice nameSummary
K2600452026-08-28Roche Molecular Systems, Inc.cobas® Cdiff Nucleic acid test for use on the cobas®…PDF
K2437302025-02-28Cepheid®Xpert C. difficile/EpiPDF
K2320922023-11-14Vela Operations USAGreat Basin Toxigenic C. difficile Direct Test (CDF2…PDF

3 summaries are archived here for direct download.

Official FDA classification page: OZN
Classification and pathway per current FDA publications. Data from openFDA (CC0).